Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-QB: AMEH), an integrated physician-centric healthcare delivery company, today announced the launch of ApolloMed Care Clinics, which will serve as both primary care medicine and post-discharge centers of excellence. As part of this strategy, ApolloMed has acquired three primary care clinics and started a de novo clinic. The clinics are located within ApolloMed’s core service areas in Los Angeles. The three acquired clinics have served their communities for a combined total of more than 75 years, handle approximately 20,000 patient visits per year and provide adult primary care and pediatric services, as well as lab and imaging services. The clinics will focus on the efficient delivery of ambulatory treatment and ancillary services, with an increasing emphasis on preventive care and management of chronic conditions. ApolloMed plans to differentiate its clinics by providing highly integrated comprehensive medical care for the entire family in anticipation of the on-going transformation of healthcare to value-based outcomes. The clinics will also serve as post-discharge centers for patients who have just left the hospital. The future of healthcare delivery calls for all healthcare providers to reduce spending and improve the overall quality of care. The Affordable Care Act incentivizes physicians based on quality metrics, value over volume and encourages providers to treat patients outside of the hospital. This paradigm shift is taking care from its traditional delivery center, the hospital, to outpatient facilities. Additionally, the influx of newly insured individuals and the aging baby-boomer population will lead to more people requesting care in an outpatient setting. Ed Rotan, Senior Vice President of Apollo Medical Holdings’ Maverick Medical Group, stated, “We provide our physician partners with a compelling value proposition. They gain access to our operational support infrastructure that utilizes highly advanced clinical applications and technology, and we conduct marketing and member relations services aimed at increasing patient flow. In short, we provide services that allow our physician partners to spend more time practicing quality medicine and less time on administrative functions.”
“We are pleased to partner with local physicians to help expand their practices and improve access to managed care contracts through our relationships. We will continue to partner with independent doctors in the community who need the support of integrated groups to provide a higher level of service to their patients,” stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. “As the nation’s healthcare model continues to rapidly change and the number of insured patients without a primary care physician increases, ApolloMed intends to meet the needs of patients with easily accessible, high-quality primary care.”About Apollo Medical Holdings, Inc. (ApolloMed)ApolloMed is a leading provider of physician-centric, integrated healthcare management services, fueled by its commitment to provide exceptional multi-disciplinary care in the communities it serves in Southern and Central California. ApolloMed is addressing the healthcare needs of the nation’s largest population center by leveraging its integrated healthcare delivery platform comprised of three affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization) and Maverick Medical Group (Independent Physician Association). This platform combines hospitalist medicine, critical care medicine, case management and transition management that enable healthcare organizations to engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. For more information, please visit www.apollomed.net. Forward Looking Statements This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. (“the Company”). In particular, when used in the preceding discussion, the words “predicts,” "believes," "expects," "intends," “seeks,” “estimates,” "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as “will,” “may,” “might,” “should,” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended January 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.